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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Childhood tuberculosis (TB) continues to be a major public health
problem in Taiwan. Taiwan remains a highly endemic area despite neonatal Bacillus
CalmetteeGue´rin (BCG) vaccination and the availability of anti-TB therapy. The presentation
is highly variable and it is often difficult to make an accurate diagnosis. This study was de-
signed to evaluate the demographic, clinical, and laboratory findings and outcomes of TB in
children with emphasis on central nervous system (CNS) complications.
Methods: The medical records of 80 children diagnosed with TB at a medical center in southern
Taiwan over the past 24 years (1988e2012) were reviewed.
Results: Among them, 48.8% (39/80) had pulmonary TB, 27.5% (22/80) had isolated extrapul-
monary TB, and 23.7% (19/80) had disseminated TB. Most infected cases were aged
either < 4 years or > 12 years. TB contact history was found in 42.5% (34/80) cases. Fourteen
(17.5%) of the cases had CNS involvement. The most common presentations were fever
(85.7%), signs of increased intracranial pressure (71.4%), drowsiness (64.3%), and focal neuro-
logical signs (57.1%). The major radiological findings were tuberculoma (50%), basilar enhance-
ment (41.6%), infarction (41.6%), hydrocephalus (16.6%), and transverse myelitis (16.6%). The
case fatality of CNS TB was 14.3% and 21.4% had neurologic sequelae.
Conclusion: Findings suggest that positive exposure history and suspicious clinical presenta-
tions are important clues for further confirmatory laboratory and image studies in childhoodof Pediatrics, National Cheng Kung University Hospital, 138 Sheng-Li Road, Tainan 70403, Taiwan.
du.tw (C.-C. Liu).
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504 Y.-H. Cho et al.TB. CNS TB usually presented as part of disseminated TB in children. Early diagnosis and treat-
ment may lead to favorable outcomes in CNS TB.
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reserved.Introduction
According to the World Health Organization, at least half a
million children become ill with tuberculosis (TB) each
year. It is estimated up to 70,000 children die of TB every
year.1 Pulmonary diseases constitute 70e80% of childhood
TB infection. Disease patterns are different between chil-
dren and adults. Infants and young children are at
increased risk of severe disseminated disease associated
with high mortality, such as miliary TB or central nervous
system (CNS) TB. Adolescents are at particular risk of
developing adult-type disease.1 Due to nonspecific symp-
toms and difficulties in diagnosis, the diagnosis of TB in
children is still a challenge. Taiwan remains a high endemic
area despite universal neonatal Bacillus CalmetteeGue´rin
(BCG) vaccination and active surveillance with anti-TB
therapy. Data from Taiwan’s National Tuberculosis Regis-
try show that there were 57.2 TB cases/100,000 population
in 2010, and the incidence of TB in persons aged < 18 years
was 9.61/100,000 personeyears.2 Childhood TB is an
important public health issue because acquisition of TB
infection during childhood contributes to the future reser-
voir of cases.3 CNS TB may cause permanent neurologic
complications or death in spite of specific anti-TB therapy.
The incidence of CNS TB is low, ranging from 2% to 5% of all
childhood TB cases.2,3 The mortality rate is estimated to
range from 15% to 32% and varies according to clinical
stage.4,5 Advanced stage TB meningitis and hydrocephalus
on admission are associated with poor prognosis.6 Early
diagnosis may prevent neurologic complications or devas-
tating outcomes. Only a few reports on childhood TB and
CNS TB are available in Taiwan.2,7e9 Further, severe child-
hood TB diseases and the mortality of CNS TB remain high
even under effective anti-TB treatment. The objective of
this study was to investigate the characteristics of child-
hood TB with emphasis on CNS complications at a medical
center in southern Taiwan during a period of 24 years.Materials and methods
Patient enrollment
Patients aged < 18 years diagnosed with TB diseases at
National Cheng Kung University Hospital from January 1988
to June 2012 were enrolled. Demographic characteristics,
clinical features, diagnostic methods, underlying diseases,
laboratory findings, treatment regimens, and outcomes
were retrieved from chart review. The diagnosis of TB
diseases was based on positive results of acid-fast stain
(AFS) smears, mycobacterium cultures, polymerase chain
reactions (PCR), or histopathological findings or clinicalmanifestations with contact history of the index case or
favorable response to anti-TB therapy.
Case definition
TB disease was categorized according to the site of
involvement as pulmonary TB, isolated extrapulmonary TB
(EPTB), and disseminated TB. The definition of pulmonary
TB was disease confined to lung, pleura, and intrathoracic
lymph nodes. Isolated EPTB was disease confined to one
extrapulmonary organ. Disseminated TB was defined as: (1)
positive AFS bacilli or TB culture or TB-PCR from blood,
bone marrow, liver, or specimens from more than two
noncontiguous organs; (2) positive AFS bacilli or TB culture
or TB-PCR from one organ and typical histopathological
findings in another noncontiguous organ; or (3) positive AFS
bacilli or TB culture or TB-PCR from one organ and radio-
graphic findings of miliary lung or CNS lesions.7 CNS TB
cases were defined as microbiologic or clinical cases. The
microbiological case definition was: (1) positive AFS bacilli
or TB culture or TB-PCR from cerebrospinal fluid (CSF); or
(2) abnormal neurologic signs and symptoms, CSF or brain
image consistent with CNS TB, and positive AFS bacilli or TB
culture or TB-PCR from any site. The clinical case definition
presented two or more of the following: (1) close TB con-
tact history; (2) CSF abnormalities without evidence of
other infectious cause; (3) brain computed tomography or
magnetic resonance imaging findings consistent with CNS
TB and response to anti-TB therapy.5
Clinical staging of TB meningitis
Clinical staging of TB meningitis was classified by the
Medical Research Council staging.10 In Stage I, patients
were fully conscious and did not have focal neurological
signs; in Stage II, patients were inattentive, confused, and
showed signs of clouding consciousness or had focal
neurological signs; in Stage III, patients were stuporous or
comatose or had multiple cranial nerve palsies or complete
hemiplegia or paraplegia.
Treatment outcomes
According to World Health Organization guidelines,11
treatment outcomes of TB patients were categorized as
cured, died, or treatment failure. Cured patients were
defined as being sputum-smear negative in the last month
of treatment. Died patients referred to those who died for
any reason during the course of treatment. Treatment
failure was defined as sputum-smear positive at 5 months or
later after starting treatment.
Figure 1. Case numbers of childhood tuberculosis (TB) dur-
ing a period of 24 years in a single medical center.
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Statistical analysis was done using SPSS software (Statistical
Package for Social Sciences, version 12.0; SPSS Inc., Chi-
cago, IL, USA). Categorical variables were analyzed using
the ManneWhitney U test, Chi-squared test, and ANOVA. A
p-value < 0.05 was considered statistically significant.
Results
Demographic characteristics and diagnostic
methods
Eighty patients with TB diseases were reviewed during a
period of 24 years in a single medical center. More cases
were diagnosed during 2001e2012 (61.3%, 49/80) than the
previous 12 years (38.7%, 31/80; Fig. 1). Overall, 39/80
(48.8%) had pulmonary TB, 22/80 (27.5%) had isolated
EPTB, and 19/80 (23.7%) had disseminated TB (Table 1).
The mean age was 9.9  6.6 years (range, 1 month to 18
years) with male-to-female ratio of 1.1 (42/38). A bimodal
age distribution was noted in TB disease, which peaked at
0e4 years and 12e18 years (Fig. 2). The age of pulmonary
TB was older than isolated EPTB and disseminated TBTable 1 Anatomical distribution of 80 children with tuberculos
Type Organ in
Pulmonary tuberculosis (n Z 39) Lung
Isolated extrapulmonary tuberculosis (n Z 22) Lymph n
CNS
Skeleta
Soft tiss
Disseminated tuberculosis (n Z 19) CNS and
GI and l
Skeleta
CNS and
bone
Soft tiss
CNS Z central nervous system; GI Z gastrointestinal.(p < 0.05). Eleven patients (13.8%) had underlying disease,
including human immunodeficiency virus (HIV) infection,
malignancy, connective tissue disease, prematurity, im-
munodeficiency disease, renal disease, and epilepsy.
Higher rates of TB contact history and positive culture re-
sults were more frequently found in children with pulmo-
nary and disseminated TB than those with isolated EPTB
(p < 0.05). Tuberculin skin test was positive in 69.2% (36/
52). The AFS smear, TB culture, and TB PCR positive rates
were 42.7% (32/75), 57.6% (39/66), and 76.2% (32/42),
respectively (Table 2).
Anatomical distribution, laboratory data, and
outcomes
The most common sites of isolated EPTB infections were
lymph nodes (7/22, 31.8%), CNS (6/22, 27.3%), and skeletal
system (6/22, 27.3%). However, lung (18/19, 94.7%), CNS
(8/19, 42.1%), and gastrointestinal system (8/19, 42.1%)
were predominantly involved in disseminated TB (Table 1).
Patients with disseminated TB had significantly higher
platelet counts, lower hemoglobin, and higher C-reactive
protein levels. Isolated EPTB had significantly lower C-
reactive protein levels than the other two groups (p < 0.05;
Table 3). The majority of these patients responded well to
anti-TB therapy, except for three with relapses (3.8%), five
with treatment failures (6.3%), and three fatal cases (3.8%).
Factors of treatment failures may include poor drug
compliance before directly observed treatment short-
course policy, anti-TB drug resistance, and HIV infection.
The causes of deaths included pneumothorax, lung cavita-
tions with intractable hemoptysis, and deep coma with
brain swelling.
Characteristics of CNS TB cases
In this series, 14 patients fulfilled the criteria for CNS TB
(Table 4). Half of the patients had concomitant pulmonary
TB and four presented with miliary pattern. Eight of them
presented with disseminated TB. A bimodal age distribution
was noted with a two-peak range, at age < 4 years (50%)
and > 10 years (43%). Half of the patients had household TB
contact history. The most common clinical manifestationsis
volvement n (%)
39 (100)
ode 7 (31.8)
6 (27.3)
l system 6 (27.3)
ue 3 (13.6)
lung 6 (31.6)
ung and/or lymph node 6 (31.6)
l and lung and/or bone marrow 3 (15.8)
GI and skeletal and/or lung/urogenital/
marrow
2 (10.5)
ue and lung and/or lymph node 2 (10.5)
Figure 2. Age distribution of 80 children with tuberculosis
(TB).
506 Y.-H. Cho et al.were fever (85.7%), symptoms of increased intracranial
pressure (headache/nausea/vomiting; 71.4%), drowsiness
(64.2%), and other focal neurological signs (facial palsy/
limb weakness; 57.1%). Ten (71.4%) patients had hypona-
tremia (serum sodium level < 130 meq/L). The tuberculin
skin test was positive in only two patients who were tested
(2/11, 18.2%). Microscopic examination of CSF failed to
identify any AFS bacilli. Microbiological evidence of TB
infection was obtained in 11 (78.5%) of these patients from
either CSF, gastric aspirates, or other tissues. The radio-
logical findings in 12 cases included tuberculoma (50%;
Fig. 3), basilar enhancement (41.6%; Fig. 3), infarction
(41.6%; Fig. 4), hydrocephalus (16.6%), and transverse
myelitis (16.6%). According to the stage of TB meningitis,
one patient was in Stage I (7%), seven in Stage II (50%), and
six in Stage III (43%). Five of the patients in Stage II received
concurrent steroid treatment with anti-TB therapy and only
one case had sequelae of mental retardation. The out-
comes of patients in Stage III were generally poor, including
two deaths (respiratory failure and brain swelling) andTable 2 Comparison of demographic characteristics and diagn
category
Characteristics and methods Pulmonary TB, n (%) Iso
No. (%) 39 (48.8) 22
Female 21 (53.8) 8 (
Age (y, mean  SD) 12.4  6.2a,b 6.4
Underlying disease 5 (12.8) 1 (
Contact history 19 (48.7)a 4 (
TST test 16/19 (84.2) 12/
Acid fast stain 17/36 (47.2) 6/2
TB culture 22/30 (73.3)a 2/1
TB PCR 14/18 (77.8) 10/
Histology d 14/
a Pulmonary TB vs. isolated EPTB, p < 0.05.
b Pulmonary TB vs. disseminated TB, p < 0.05.
c Isolated EPTB vs. disseminated TB, p < 0.05.
EPTB Z extrapulmonary TB; PCR Z polymerase chain reaction; SD Zsignificant neurological sequelae in three cases (i.e.,
hydrocephalus with shunt surgery, paraplegia, urinary
retention). Paradoxical responses during anti-TB therapy
were found in five of the patients.
Discussion
The global burden of childhood TB is underestimated due to
the difficulty in confirming the diagnosis and lower
reporting of cases. The current study demonstrated that
childhood TB continues to be an important issue in Taiwan.
More cases were diagnosed during 2001e2012 than in the
previous 12 years. The risk of disseminated or CNS TB
following primary infection is greatest in children aged < 4
years, around 10e20% in those aged < 1 year, and 2e5%
when aged 1e2 years.12 The disease incidence decreased to
a nadir at age 5e10 years and increased rapidly in adoles-
cence.13 The result of our study is in line with this ten-
dency. Age-related differences in disease patterns probably
reflect differences in immunological status.
Diagnosis of disseminated TB in children is difficult
because the clinical manifestations may be nonspecific,
including poor appetite, failure to thrive, and prolonged
fever. The risk factors for disseminated TB include HIV
infection, medication with immunosuppressive drugs, im-
munodeficiencies such as chronic granulomatous disease,
and Mendelian susceptibility to mycobacterial diseases.7,11
In our series, 26.3% (5/19) disseminated TB had underlying
diseases. Wang et al reported that the most common or-
gans involved in disseminated TB in adults were the lung
(87.2%), the musculoskeletal system (19.5%), and the
urogenital system (17.1%).7 In our study, the major
involved organs were the lung (94.7%), the CNS (42.1%),
and the gastrointestinal system (42.1%). Only two of our
patients underwent bone marrow examination. Both
specimens showed positive culture results and the typical
caseating granuloma. Bone marrow examination should be
considered in patients with clinically suspected dissemi-
nated TB.
Superficial lymphadenitis ranges from 46% to 67%.9,14 In
our study, only 31.8% of patients with isolated EPTB hadostic methods of children with tuberculosis (TB) by disease
lated EPTB, n (%) Disseminated TB, n (%) p
(27.5) 19 (23.7)
36.4) 9 (47.4) 0.386
 5.1 8.9  7.0 0.002
4.5) 5 (26.3) 0.127
18.2)c 11 (57.9) 0.02
20 (60) 8/13 (61.5) 0.206
0 (30.0) 10/19 (52.6) 0.340
8 (11.1)c 14/18 (77.8) <0.001
14 (71.4) 8/10 (80) 0.91
22 (63.6) 8/19 (42.1) 0.168
standard deviation; TST Z tuberculin skin test.
Table 3 Comparison of laboratory findings of children with tuberculosis (TB) by disease category
Pulmonary TB Isolated EPTB Disseminated TB p
WBC (109/L) 11.1  5.5 12.2  6.3 11.6  4.7 0.772
Segment (%) 59.8  19.1 56.2  19.9 62.3  15.1 0.595
Band (%) 8.9  8.3 4.5  5.9 9.3  9.4 0.212
Lymphocyte (%) 24.9  19.4 27.7  16.4 19.5  13.2 0.344
Hb (g/L) 125  18b 123  17c 104  21 0.001
Platelet (1012/L) 344  136a,b 452  102 473  166 0.003
CRP (mg/L) 59.1  62.9a 24.1  33.7c 120.9  227.5 0.095
AST (U/L) 36.1  24.3 34.9  13.7 42.4  40.3 0.441
ALT (U/L) 29.6  24.5 27.3  12.7 32.8  30.9 0.79
ESR (mm/h) 49.8  38.8 37.5  32.6 65.4  45.8 0.26
a Pulmonary TB vs. isolated EPTB, p < 0.05.
b Pulmonary TB vs. disseminated TB, p < 0.05.
c Isolated EPTB vs. disseminated TB, p < 0.05.
ALT Z alanine aminotransferase; AST Z aspartate aminotransferase; CRP Z C-reactive protein; EPTB Z extrapulmonary TB;
ESR Z erythrocyte sedimentation rate; Hb Z hemoglobin; WBC Z white blood cell count.
Childhood tuberculosis in southern Taiwan 507lymphadenitis, which is less than the previous report.9 Most
of the TB lymphadenitis was diagnosed by histopathologic
findings, tuberculin skin tests, and contact histories. Lack
of mycobacterium culture results or molecular evidence
may make it difficult to differentiate from non-TB myco-
bacterium lymphadenitis. Clinicians should be alert to the
diagnosis of cervical TB lymphadenitis and look for micro-
biological or molecular evidence of M. tuberculosis infec-
tion. Bone is also a frequently involved organ in EPTB. The
proportion of skeletal TB in our study was 27.3%, which was
compatible with the previous report (27e35%).9
CNS TB is the most severe, life-threatening form of TB in
young children and accounts for approximately 5% of pa-
tients.2 Up to 79% of children with CNS TB are aged < 5
years,15,16 which is higher than our series (8/14, 57%). The
most common presentations of CNS TB in this study were
fever, symptoms of increased intracranial pressure, altered
consciousness, and focal neurological deficits. Seizure was
observed in three patients (3/14, 21.4%), which is less
frequent than other childhood study (50%).17 Cranial nerve
deficits were found in 30e50% of cases, which most
commonly involved sixth and seventh cranial nerves.17
However, only two cases (14.3%) had seventh cranial
nerve involvement in our series. Young age and late-stage
presentation are usually associated with poor outcomes.18
Therefore, in young children with meningitis and house-
hold TB contact history, CNS TB should be listed as a dif-
ferential diagnosis.
The tuberculin skin test in CNS TB was positive in only
18.2% (2/11) of our patients, which was much lower than
other TB disease (69.2%). The positive rate was similar with
previous study, which ranged from 10e30% in children with
CNS TB.5,19,20 A negative tuberculin skin test did not
exclude the possibility of TB diseases because disseminated
TB, including meningitis and miliary, may induce an anergic
reaction to the skin test.
About 10e18% of patients with CNS TB have been re-
ported to have a so-called paradoxical response.2,21 These
phenomena generally occur within 3 months after treat-
ment and do not represent treatment failure.21e23 The
paradoxical response in CSF (lymphocyte predominant shiftto segment predominant) during anti-TB therapy was
observed in 35.7% (5/14) of our patients and two of them
had clinical deterioration.
In this study, no AFS bacilli could be found in CSF and
M. tuberculosis cultures were positive in only 21.4%. The
identification rate of AFS bacilli in CSF was 80% in adult, but
only 10e20% in children, whereas the positive culture rate
ranged from 30% to 74%.5,11 It had been postulated that a
higher volume of CSF (> 6 mL) and taking more samples
increases bacteriological yield rate.3,24 Thwaites et al re-
ported that > 6 mL fluid tapping was safe for infants and
children.24 We suggest that repeated lumbar punctures and
a higher CSF volume may increase the bacteriological
detection rate in CSF. The molecular method of TB-PCR has
been used in the diagnosis of CNS TB.25 In our study, eight
patients (8/11, 73%) had positive TB-PCR results in CSF.
Mycobacterial DNA remained identifiable within the CSF
even after 1 month of anti-TB treatment,20 which may
provide more chance for mycobacterium detection. Many
new modalities, such as interferon-g assay, urine lip-
oarabinomannan, and Xpert MTB/RIF test, have been
applied to the diagnosis of TB infection.26e28
Kumar et al reported basilar enhancement, hydroceph-
alus, tuberculoma, and infarctions as typical findings of CNS
TB.29 The reported incidence was 75e92% for basilar
enhancement, 68e100% for hydrocephalus, and 10e27% for
tuberculoma. Andronikou et al found that hyperdensity in
the basal cisterns before contrast is the most characteristic
image finding on computed tomography.30 The incidence of
hydrocephalus correlated with the duration of disease.
Only two patients (14.3%) had complication of hydroceph-
alus in our cases, which may be due to earlier diagnosis and
treatment. Tuberculoma (50%) is more common in our se-
ries. Tuberculoma may develop before or during the course
of treatment.31
Despite anti-TB treatment for tuberculous meningitis,
mortality remains high. The current treatment recommen-
dation consists initially of 2 months of isoniazid, rifampicin,
pyrazinamide, levofloxacin or moxifloxacin, and amino-
glycoside or prothionamide, followed by 10 months of
isoniazid and rifampicin.32,33 Isoniazid, pyrazinamide, and
Table 4 Descriptions of 14 children with central nervous system (CNS) tuberculosis (TB)
N
Age, sex Stage Sites of
infection
Contact
history
Presenting
symptoms and
signs
Imaging findings CSF findings
WBC (106/L)
Lactate (mM)
Diagnostic
methods
Treatment
regimens
Steroid Outcome
1 10 y, F I CNS
Lung
Y Fever 4 wk, cough,
headache,
vomiting
1. Infarction
over pos, right
MCA
2. Right Sylvian
tuberculoma
with encase-
ment of MCA
WBC: 13
Lactate: 3.1
CSF and gastric
lavage culture: Pos
INH (13 mo)
RIF (13 mo)
PZA (3 mo)
EMB (3 mo)
SM (2 wk)
N Survival
2 13 y, F II CNS
Lung
Y Fever, headache,
nausea, slurred
speech,
drowsiness,
photophobia
1. Infarct at
bilateral basal
ganglia, left
frontal area,
temporal
lobes
2. Lep-
tomeningeal
enhancement
over pons and
midbrain
3. Tuberculoma
at bilateral
frontal , left
occipital
lobes, CNS
WBC: 360
Lactate: 5.1
CSF and gastric
lavage culture: Pos
CSF and gastric
lavage PCR: Pos
INH (12 mo)
RIF (12 mo)
PZA (3 mo)
EMB (3 mo)
AMK (2 mo)
TBN (4 mo)
LEV (4 mo)
Y Survival
3 2 mo, M II CNS Y Fever, vomiting,
drowsiness,
irritable
No focal lesion in
CNS
WBC: 360
Lactate: 1.4
CSF PCR: Pos Lost to follow-up N Lost to follow-up
4 6 mo, M II CNS
Skeletal
GI
Y Left lower limb
weakness for 1
mo, diarrhea
Tuberculoma over
bilateral frontal,
left occipital, right
pons and T11-12
spine
WBC: 7
Lactate: 1.4
Gastric lavage
culture: Pos
Retroperitoneal
abscess PCR: Pos
INH (12 mo), RIF
(12 mo), PZA
(3 mo),
EMB (2 mo), SM
(1 mo)
Y Survival
5 12 y, M II CNS N Fever, headache
ataxia, slurred
speech, vomiting,
drowsiness
No focal lesion in
CNS
WBC: 216
Lactate: 3.2
CSF PCR: Pos Lost to follow-up Y Lost to follow-up
6 13 y, F II CNS N Fever 2 wk,
headache, neck
stiffness,
vomiting,
drowsiness
No image WBC: 84l
Lactate: 3.5
CSF PCR: Pos INH (12 mo), RIF
(12 mo), PZA
(3 mo),
EMB (2 mo)
Y Survival
508
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9 6 mo, M III CNS
Lung
Y Fever 2 d,
vomiting, seizure,
limb weakness,
failure to thrive,
bulging fontanel
1. Infarction at
pons and basal
ganglion
2. Tuberculoma
over pons,
right sylvian
fissure
WBC: 231
Lactate: 2.4
Gastric lavage
culture: Pos
Lost to follow-up Y Lost to follow-up
10 4 y, M III CNS
Lung
Y Bilateral lower
limb paralysis and
anesthesia for 7 d,
urine and stool
retention
T3eT9 transverse
myelitis
WBC: 1
Lactate: 1.9
CSF and Gastric
lavage PCR: Pos
INH (12 mo)
RIF (12 mo)
PZA (2 mo)
EMB (2 mo)
Y Survival
Paraplegia
11 2 y, M III CNS N Fever 4 wk,
seizure, aphasia,
ataxia
Hydrocephalus
with basilar
enhancement
WBC: 121
Lactate: 2.4
CSF PCR: Pos INH (12 mo)
RIF (12 mo)
PZA (2 mo)
SM (1 mo)
Y Survival
Shunt surgery,
Mental retardation
12 17 y, M III CNS N Fever 17 d,
headache,
vomiting,
drowsiness, urine
retention and
bilateral leg
weakness
T7-8 myelitis WBC: 470
Lactate: 2.4
Image and clinical
response
INH (9 mo)
RIF (9 mo)
PZA (2 mo)
EMB (9 mo)
SM (1 mo)
Y Survival
Voiding
dysfunction
13 6 y, F III CNS N Fever 2 wk,
vomiting,
lethargy, seizure
No image WBC: 100
Lactate: 2.1
CSF PCR: Pos INH (12 mo)
RIF (12 mo)
PZA (2 mo)
EMB (2 mo)
N Survival
14 5 mo, F III CNS
Lung
Skeletal
GI
Renal
N Fever 4 wk, cough,
poor appetite,
failure to thrive,
hemiplegia
1. Lep-
tomeningeal
enhancement
at basal and
prepontine
cistern
2. Infarcts at
bilateral ACA,
MCA and right
PCA territories
3. Tuberculoma
at right
cerebellum
WBC: 18
Lactate: 3.4
CSF, gastric
lavage, urine
culture: Pos CSF
and gastric
lavage PCR: Pos
INH (7 wk)
RIF (7 wk)
PZA (7 wk)
PTN (3 wk)
Y Expired,
Respiratory failure
with tension
pneumothorax
ACA Z anterior cerebral artery; AMK Z amikacin; CN Z cranial nerve; CNS Z central nervous system; EMB Z ethambutol; F Z female; GI Z gastrointestinal; INH Z isoniazid;
LEV Z levofloxacin; M Z male; MCA Z middle cerebral artery; N Z no; PCA Z posterior cerebral artery; PCR Z polymerase chain reaction; Pos Z positive; PTN Z prothionamide;
PZA Z pyrazinamide; RMP Z rifampicin; SM Z streptomycin; WBC Z white blood cell count; Y Z yes.
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Figure 3. Magnetic resonance image of a 13-year-old girl
showing enhanced nodules and plaques along basal, pre-
pontine, and ambient cisterns.
510 Y.-H. Cho et al.fluoroquinolone show good cerebrospinal fluid penetration,
but rifampicin does not. However, rifampicin is crucial in
the treatment of TB meningitis because of the high mor-
tality in patients with rifampicin-resistant disease. Recent
data show that treatment containing a higher dose of
rifampicin and moxifloxacin is associated with a survival
benefit in patients with tuberculous meningitis.33 However,
most of the data regarding the therapy of TB meningitis
with fluoroquinolone were from adults. Fluoroquinolone
treatment in childhood TB meningitis needs further clinical
investigations.Figure 4. Magnetic resonance image of a 5-month-old girl
showing vasculitis-related infarcts at bilateral anterior cere-
bral artery, bilateral middle cerebral artery, and right poste-
rior cerebral artery territories.Corticosteroid also improved survival and neurological
outcomes in children with Stage II and Stage III TB menin-
gitis.34 In our experience, 10 (76.9%) of 13 patients in Stage
II and Stage III received adjuvant steroid therapy and the
outcome was generally good except for three (23.1%) in
Stage III with sequelae of mental retardation, paraplegia,
and voiding dysfunction; two of these patients died.
In conclusion, cases of childhood TB have increased in
the past decade. This is probably due to higher clinical
alertness and improved diagnostic modalities. A bimodal
age distribution was noted in pulmonary and disseminated
TB. Children with pulmonary and disseminated TB are more
likely to have positive contact histories and culture results.
An aggressive diagnostic approach and effective treatment
are crucial for the prognosis of CNS TB because delayed
diagnosis and treatment are associated with poor out-
comes. CNS TB usually presents as part of disseminated or
miliary TB in children. Therefore clinical manifestations,
household contact history, CSF analysis, molecular micro-
biological method, image studies, and a search for other
organ involvements are important for prompt diagnosis and
treatment of CNS TB. Early diagnosis and treatment may
lead to favorable outcomes in CNS TB.Conflicts of interest
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